
Understanding treatments for severe alopecia: A comparative look at options
Explore the latest treatments for severe alopecia, including JAK inhibitors like Litfulo, and compare them with other options for hair loss.
Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993
For visual reference only; actual product may vary
US Name:
Litfulo
Alternative Names:
Litfulo
Active Ingredients:
Ritlecitinib
Brand Manufacturer:
Pfizer
Manufacturer Location:
Germany
Click here to view Product Insert
Click here to view Product Insert
For visual reference only; actual product may vary
Litfulo (ritlecitinib) is an oral, once-daily prescription medication for treating severe alopecia areata in adults and adolescents 12 years and older. By targeting specific enzymes, it helps reduce the inflammation that causes hair loss, promoting natural regrowth of hair.
| Litfulo Brand | 50mg 28 Tablets |
-
|
Our price: $1,015.00 |
Litfulo (ritlecitinib) is a once-daily oral medication used to treat severe alopecia areata in people 12 years and older. Alopecia areata is an autoimmune disease where the body’s own immune system attacks hair follicles. This attack causes hair to fall out, often in patches on the scalp, face, or body. Litfulo is part of a class of drugs known as Janus kinase (JAK) inhibitors. It works by calming the immune response that leads to this hair loss. The goal of treatment is to allow hair to regrow naturally.
Litfulo works by targeting and blocking specific enzymes in the body that cause inflammation and hair loss. These enzymes are called Janus kinase 3 (JAK3) and TEC family kinases. They play a key role in signaling the immune system to attack hair follicles. By inhibiting these enzymes, Litfulo reduces the inflammation around the follicles. This action stops the immune attack. As a result, the hair follicles can recover and begin to grow hair again. It is a targeted therapy designed to interrupt the specific cycle causing alopecia areata.
Litfulo is intended for adults and adolescents aged 12 and over who have been diagnosed with severe alopecia areata. This medication is for patients with significant hair loss affecting their quality of life. A doctor must evaluate your condition to determine if Litfulo is the right choice. It is often considered for those who have not had success with other treatments, such as topical creams or injections. Patients must be willing to undergo regular monitoring by their doctor to track progress and manage potential side effects.
Litfulo is administered as a single 50 mg capsule taken orally once each day. You can take the capsule with or without food. It should be swallowed whole with a glass of water. Do not crush, split, or chew the capsule, as this can change how the medication works. If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed one. Never take two doses at once. Always follow the specific instructions provided by your healthcare provider for the best results.
Litfulo may cause side effects, though many people experience only mild issues or none at all. The most common side effects include headache, diarrhea, acne, rash, and upper respiratory tract infections. Because Litfulo works on the immune system, it can increase your risk of more serious infections. Your doctor will monitor you for signs of infection. In rare cases, more serious effects like shingles, low blood cell counts, or liver problems can occur. Discuss all potential risks with your doctor before starting treatment. This is not a complete list of possible side effects.
IsraelPharm offers a reliable and convenient way to access authentic medications like Litfulo directly from a trusted source. We provide competitive pricing on brand-name drugs, helping you save on your treatment costs. All medications are dispensed from a licensed pharmacy and shipped in manufacturer-sealed packaging. Our knowledgeable customer service team is here to assist you with your order. You can be confident you are receiving genuine Litfulo delivered discreetly to your door. We make managing your prescription simple and affordable.
The most common side effects of Litfulo are generally mild to moderate. They may include:
Litfulo can lower your immune system’s ability to fight infections. Some infections can become serious. Your doctor will monitor you before and during treatment. This is not a complete list of side effects. Always consult your doctor for medical advice.
Litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents aged 12 years and older.
Litfulo may begin to show results in a few months, but significant hair regrowth can take up to six months or longer. Patient results vary based on the severity of their alopecia areata and individual response to the treatment. Consistent daily use as prescribed by your doctor is essential to achieve the best possible outcome. Full effects are often seen after several months.
Litfulo can interact with other drugs, so it is crucial to inform your doctor about all medications you take. This includes prescriptions, over-the-counter drugs, and herbal supplements. Specifically, mention any other medications that affect your immune system, as combining them with Litfulo could increase your risk of serious infections. Your doctor will advise on any necessary adjustments.
Litfulo should be taken once daily; if you miss a dose, take it as soon as you remember that same day. However, if it is almost time for your next scheduled dose, you should skip the missed one entirely. Do not take two doses at the same time to make up for a missed one, as this can increase your risk of side effects.
Litfulo is approved for ongoing use in managing severe alopecia areata, and its long-term safety profile is established in clinical trials. Your doctor will monitor your health with regular check-ups and blood tests to manage any potential risks. These check-ups help ensure the medication remains a safe and effective treatment option for you over time. Always follow your doctor’s guidance.
Yes, your doctor will require blood tests before you start taking Litfulo and periodically during your treatment. These tests check your blood cell counts and liver function to ensure the medication is safe for you. This monitoring helps prevent potential side effects, such as anemia or liver problems, and confirms that you can continue treatment safely. It is a key safety step.
Litfulo and other JAK inhibitor medications carry a warning about a potential increased risk of certain cancers, including lymphoma and skin cancer. This risk is considered low, but it is important to discuss your personal and family medical history with your doctor. Regular skin checks and monitoring are recommended while taking this medication to ensure your long-term health and safety.
You should not receive live vaccines while being treated with Litfulo because it affects your immune system. Talk to your doctor about updating any necessary vaccinations before you begin treatment. Non-live vaccines, such as the flu shot, are generally considered safe, but you should always confirm with your healthcare provider before getting any vaccine while on this medication.
The active ingredient in Litfulo is ritlecitinib, which is a type of medication known as a Janus kinase (JAK) inhibitor. Ritlecitinib works by blocking specific cellular pathways involved in the autoimmune response that causes hair loss in alopecia areata. This targeted action helps to reduce inflammation at the hair follicle, allowing for the potential of hair regrowth.
Litfulo does not have a direct, severe interaction with moderate alcohol use, but it is wise to be cautious. Both alcohol and Litfulo can affect the liver, and your doctor will monitor your liver function during treatment. Excessive alcohol use could place additional strain on the liver. Always discuss your alcohol consumption with your doctor to ensure it is safe for your situation.
Litfulo capsules should be stored at room temperature, which is between 68°F to 77°F (20°C to 25°C). Keep the medication in its original container to protect the capsules from exposure to moisture and light. Do not store it in a bathroom. Like all medications, it is very important to keep Litfulo out of the reach of children and pets.
Litfulo is not approved for use in children under the age of 12. Its safety and effectiveness have only been established for adults and adolescents aged 12 and older with severe alopecia areata. If you are seeking treatment for a child under 12, you should consult a pediatric dermatologist to discuss other available and appropriate treatment options for their specific condition.
Litfulo does not cure alopecia areata, but it is an effective treatment for managing its symptoms. Alopecia areata is a chronic autoimmune condition. Litfulo works by suppressing the immune attack on hair follicles to allow hair to regrow. If treatment is stopped, it is possible for the hair loss to return. Consistent daily use is key to maintaining results.
Litfulo is not recommended for women who are pregnant, planning to become pregnant, or breastfeeding. There is not enough research to confirm its safety for a developing baby or a nursing infant. You should discuss your family planning with your doctor before starting treatment. If you become pregnant while taking Litfulo, you must inform your doctor immediately to discuss next steps.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

Explore the latest treatments for severe alopecia, including JAK inhibitors like Litfulo, and compare them with other options for hair loss.

For many years, managing type 2 diabetes (T2D) felt like a single-minded pursuit: get the blood sugar down. While crucial, this approach overlooked a more dangerous threat. People with type 2 diabetes are far more

In the world of psoriatic arthritis (PsA) treatments, a new head-to-head comparison has generated significant discussion. A recent study directly comparing Bimzelx and Skyrizi showed that for the primary goal of joint improvement, Bimzelx outperformed


